泡稳定通过两个复合αs1-casein的遗传变异
Vega Mora Mortes1, Anteun de Groot2, Emmanouil Chatzigiannakis3
1Laboratory of Physics and Physical Chemistry of Foods, Wageningen University, Bornse Weilanden 9, 6708WG Wageningen, Netherlands.
Journal of colloid and interface science
|February 21, 2026
概括
重组素的遗传变体,特别是α-s1-素变体A和B,表现出不同的界面行为,影响泡稳定性. 了解这些差异可以为基于素的发泡产品量身定制设计.
科学领域:
- 食品科学 食品科学 食品科学
- 生物技术是生物技术.
- 材料科学 材料科学 材料科学
背景情况:
- 精密发酵可以生产具有特定遗传变异的重组素.
- 素中的氨基酸序列变化显著影响界面,薄膜和发泡性质.
- 通过利用这些素变体,可以实现食品的有针对性的设计.
研究的目的:
- 研究α-s1-素变体A (RCA) 和B (RCB) 之间的氨基酸序列差异对它们的界面,薄膜和发泡特性的影响.
- 探索不同的界面配置 (尾列与列车环列车) 如何影响泡的稳定性.
- 评估在功能性产品设计中使用特定的复合素变体的潜力.
主要方法:
- 研究了由RCA和RCB稳定的大幅振荡扩张和剪切以及原子力显微镜 (AFM) 的空气水界面.
- 分析的薄膜通过RCA或RCB稳定,使用薄膜平衡与微干扰测量相结合.
- 使用FoamScan设备确定了两种变体的泡特性.
主要成果:
- 在低度 (0.05%) 的重组氨酸B (RCB) 形成了移动接口,促进了吉布斯-马兰戈尼流和优越的泡稳定性 (t1/2: 1小时).
- 较高的RCB度抑制了吉布斯-马兰戈尼流,降低了泡的稳定性.
- 重组素A (RCA) 形成了更硬,更不灵活的接口,抑制了吉布斯-马兰戈尼流动,导致泡稳定性降低 (t1/2: 8-20分钟),随着度的提高而改善.
- 素中的氨基酸缺失显著改变了接口和发泡行为.
结论:
- 再组合素变体的特定氨基酸序列和由此产生的界面配置极大地影响泡的形成和稳定性.
- 再组合素的遗传变异为调整食品和材料应用中的功能性质提供了强大的工具.
- 量身定制素变体为开发具有可预测性能的先进发泡产品提供了途径.
更多相关视频
相关概念视频
Protein Complexes with Interchangeable Parts
3.0K
Groups of proteins may form a complex where each protein in this complex has a different role in the overall execution of the complex’s function. Often some of the proteins in the complex can be replaced by a closely related variant to give a complex that contains many of the same components yet is functionally distinct.
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order...
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order...
3.0K
Allosteric Proteins-ATCase
6.7K
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
6.7K
Epistasis Analysis
6.0K
Although Mendel chose seven unrelated traits in peas to study gene segregation, most traits involve multiple gene interactions that create a spectrum of phenotypes. When the interaction of various genes or alleles at different locations influences a phenotype, this is called epistasis. Epistasis often involves one gene masking or interfering with the expression of another (antagonistic epistasis). Epistasis often occurs when different genes are part of the same biochemical pathway. The...
6.0K
Amyloid Fibrils
12.1K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
12.1K
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
30
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
30
Conservation of Protein Domains Over Different Proteins
14.8K
Protein domains are small structurally independent units that are part of a single amino acid chain. Although these domains are often structurally independent, they may rely on synergistic effects to perform their functions as part of a larger protein. Protein domains may be conserved within the same organism, as well as across different organisms.
A limited set of protein domains often duplicate and recombine during evolution. These domains can be organized in different combinations to...
A limited set of protein domains often duplicate and recombine during evolution. These domains can be organized in different combinations to...
14.8K


